SOMCL-085, a novel multi-targeted FGFR inhibitor, displays potent anticancer activity in FGFR-addicted human cancer models
Crossref DOI link: https://doi.org/10.1038/aps.2017.96
Published Online: 2017-09-14
Published Print: 2018-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Jiang, Xi-fei
Dai, Yang
Peng, Xia
Shen, Yan-yan
Su, Yi
Wei, Man-man
Liu, Wei-ren
Ding, Zhen-bin
Zhang, Ao
Shi, Ying-hong
Ai, Jing
Text and Data Mining valid from 2017-09-14
Article History
Received: 24 May 2017
Accepted: 20 June 2017
First Online: 14 September 2017